Logo
International Journal of
Research in Pharmacy and Pharmaceutical Sciences
ARCHIVES
VOL. 10, ISSUE 1 (2025)
Recent overview: Medication use for hyperthyroidism
Authors
Deokate Samruddhi V, Shinde Ajay D
Abstract

Excessive thyroid hormone production is the hallmark of hyperthyroidism, a disorder that seriously compromises systemic and metabolic health. Pharmacological treatments that restore hormonal balance are the mainstay of effective management. New insights into hyperthyroidism have improved treatment strategies, increasing patient safety and effectiveness. First-line treatments include antithyroid medications like Propylthiouracil (PTU) and Methimazole, which efficiently lower hormone synthesis. Although PTU is only used in certain circumstances, such as the first trimester of pregnancy, Methimazole is typically used because of its better safety profile and ease of dosage. Beta-blockers, such as Propranolol, are commonly used as adjunctive therapy to provide quick symptom alleviation for conditions like tachycardia and tremors.

The new developments in the treatment of hyperthyroidism center on individualized therapy, taking into account variables including age, comorbidities, and the severity of the condition. Furthermore, pharmacogenomics developments are starting to affect medication choice and dosage, lowering side effects and enhancing therapeutic results. Notwithstanding these developments, difficulties still exist, especially when it comes to treating refractory patients and preventing long-term issues. In order to provide more efficient and patient-centered care, research is still being done to refine current therapy paradigms and investigate new therapeutic targets. This summary emphasizes the value of treating hyperthyroidism using a multidisciplinary approach that incorporates both comprehensive patient management techniques and pharmaceutical breakthroughs.
Pages:17-22
How to cite this article:
Deokate Samruddhi V, Shinde Ajay D "Recent overview: Medication use for hyperthyroidism". International Journal of Research in Pharmacy and Pharmaceutical Sciences, Vol 10, Issue 1, 2025, Pages 17-22
Download Author Certificate

Please enter the email address corresponding to this article submission to download your certificate.